Name | Type | Posted | Actions |
|---|---|---|---|
Amendment_5to_the_RFP_-_10-18-2024_0005.pdf | Oct 18, 2024 | ||
Amendment_4_to_the_RFP_-_10-11-2024_0004.pdf | Oct 11, 2024 | ||
Amendment_3_to_the_RFP_-_10-08-2024_0003.pdf | Oct 8, 2024 | ||
Amendment_2_to_the_RFP_-_9-20-24_0002.pdf | Sep 20, 2024 | ||
Amendment_1_to_RFP_75N94024R00008_9-11-24_0001.pdf | Sep 11, 2024 | ||
Sol_75N94024R00008.pdf | Sep 4, 2024 |
A--BPCA Pediatric Trials Network
BPCA Pediatric Trials Network
Contact and place of performance
OSINSKI, ELIZABETH J
Not specified
Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN)
The National Institutes of Health, specifically the National Institute of Child Health and Human Development (NICHD), is seeking proposals for the Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN). This initiative focuses on conducting research and development to support pediatric drug labeling and therapeutics. The project is classified under NAICS 541715 for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and PSC AN11 for Health R&D Services, Health Care Services, and Basic Research.
The solicitation, identified by number 75N94024R00008, requires responses by November 4, 2024. Elizabeth J. Osinski serves as the point of contact for this requirement. The solicitation was originally published on September 4, 2024, and has since been updated with five amendments posted between September 11 and October 18, 2024. Documentation for this opportunity includes the original solicitation file and five subsequent amendment PDF documents.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.